Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
200028 On Other Exchanges
Symbol
Exchange
200028 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

china national accord medi-b (200028) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA NATIONAL ACCORD MEDI-B (200028)

Related News

No related news articles were found.

china national accord medi-b (200028) Related Businessweek News

No Related Businessweek News Found

china national accord medi-b (200028) Details

China National Accord Medicines Co., Ltd. engages in the distribution of medicine and pharmaceutical products. It also manufactures medicines. The company is based in Shenzhen, China. China National Accord Medicines Co., Ltd. is a subsidiary of Sinopharm Holding Co., Ltd.

4,431 Employees
Last Reported Date: 03/20/15

china national accord medi-b (200028) Top Compensated Officers

General Manager and Director
Total Annual Compensation: --
Chief Financial Officer
Total Annual Compensation: --
Deputy General Manager
Total Annual Compensation: --
Deputy General Manager
Total Annual Compensation: --
Deputy General Manager
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

china national accord medi-b (200028) Key Developments

China National Accord Medicines Corporation Ltd., Special/Extraordinary Shareholders Meeting, Jan 19, 2016

China National Accord Medicines Corporation Ltd., Special/Extraordinary Shareholders Meeting, Jan 19, 2016, at 14:00 China Standard Time. Agenda: To continue the major assets restructuring matters and apply for postponement of trading resumption.

China National Accord Medicines Corporation Ltd. to Report Q3, 2015 Results on Oct 24, 2015

China National Accord Medicines Corporation Ltd. announced that they will report Q3, 2015 results on Oct 24, 2015

China National Accord Medicines Corporation Ltd., Special/Extraordinary Shareholders Meeting, Sep 11, 2015

China National Accord Medicines Corporation Ltd., Special/Extraordinary Shareholders Meeting, Sep 11, 2015., at 14:00 China Standard Time. Agenda: To consider the apply for issuance of commercial paper; and to consider the adjustment to 2015 semi-annual quota of bank credit and guarantee arrangement.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
200028:CH $39.82 HKD 0.00

200028 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 200028.
View Industry Companies
 

Industry Analysis

200028

Industry Average

Valuation 200028 Industry Range
Price/Earnings 32.2x
Price/Sales 0.9x
Price/Book 4.4x
Price/Cash Flow 27.3x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHINA NATIONAL ACCORD MEDI-B, please visit www.szaccord.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.